International Transfer Pricing in the Ethical Pharmaceutical Industry

This report was originally a study commissioned by a number of leading pharmaceutical companies into the transfer pricing of ethical pharmateutical products, i.e. those products whose safety, efficacy and quality have been proven by state-of-the-art scientific methods. Since its original publication, significant developments have occurred both in the industry as a whole and in respect of transfer pricing. In light of these developments, the new edition presents a current perspective of the particular circumstances that the ethical pharmaceutical industry must take into account regarding transfer pricing.